Literature DB >> 32000891

Quantitation of calreticulin exposure associated with immunogenic cell death.

Peng Liu1, Liwei Zhao1, Oliver Kepp2, Guido Kroemer3.   

Abstract

Tumor cells treated by immunogenic cell death (ICD) inducers emit danger associated molecular patterns (DAMP), including but not limited to calreticulin (CALR), which translocates from the ER lumen to the surface of the cellular membrane where it serves as de novo uptake signal for antigen presenting cells of the immune system. CALR is exposed at an early stage of ICD and dictates tumor antigen transfer and therefore the immunogenicity of cancer cell death. Here, we provide a bi-color flow cytometry protocol for the quantification of ICD-associated CALR cell surface exposure in fixed samples. As compared to the detection of surface exposed CALR by confocal microscopy, the present flow cytometry-based analysis is cost-efficient and does not require sophisticated equipment. Moreover, the staining panel can be extended to a multicolor analysis for the parallel assessment of additional parameters.
© 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anthracyclines; Cancer; Danger-associated molecular patterns; Flowcytometric analysis; Immunogenic cell death

Mesh:

Substances:

Year:  2019        PMID: 32000891     DOI: 10.1016/bs.mie.2019.05.011

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  4 in total

1.  Alternol triggers immunogenic cell death via reactive oxygen species generation.

Authors:  Changlin Li; Ying Zhang; Siyuan Yan; Guoan Zhang; Wei Wei; Zhi Qi; Benyi Li
Journal:  Oncoimmunology       Date:  2021-07-21       Impact factor: 8.110

2.  Carbon ion radiotherapy triggers immunogenic cell death and sensitizes melanoma to anti-PD-1 therapy in mice.

Authors:  Heng Zhou; Chen Tu; Pengfei Yang; Jin Li; Oliver Kepp; Haining Li; Liying Zhang; Lixin Zhang; Yang Zhao; Tianyi Zhang; Chengyan Sheng; Jufang Wang
Journal:  Oncoimmunology       Date:  2022-03-25       Impact factor: 8.110

Review 3.  Current clinical landscape of oncolytic viruses as novel cancer immunotherapeutic and recent preclinical advancements.

Authors:  Chae-Ok Yun; JinWoo Hong; A-Rum Yoon
Journal:  Front Immunol       Date:  2022-08-25       Impact factor: 8.786

4.  Pharmacological inhibitors of anaplastic lymphoma kinase (ALK) induce immunogenic cell death through on-target effects.

Authors:  Adriana Petrazzuolo; Maria Perez-Lanzon; Isabelle Martins; Peng Liu; Oliver Kepp; Véronique Minard-Colin; Maria Chiara Maiuri; Guido Kroemer
Journal:  Cell Death Dis       Date:  2021-07-16       Impact factor: 8.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.